(Q46969882)

27 December 2017

title

Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure (English)

1 reference

27 December 2017

0 references

1 reference

1 reference

chronic heart failure

1 reference

H. Gogia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

A. Mehra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

S. Parikh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

M. Raman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

J. Ajit-Uppal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

J. V. Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

U. Elkayam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594088

2 June 2024

language of work or name

English

0 references

publication date

1 December 1995

1 reference

27 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0735109795003681?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

https://api.elsevier.com/content/article/PII:0735109795003681?httpAccept=text/plain

2 June 2024

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Journal of the American College of Cardiology

2 June 2024

published in

1 reference

27 December 2017

volume

26

1 reference

27 December 2017

issue

7

1 reference

27 December 2017

page(s)

1575-1580

1 reference

27 December 2017

Use of nitrates in ischemic heart disease

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

2 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Solving the mystery of nitrate tolerance. A new scent on the trail?

2 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine

2 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

2 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

2 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure

2 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

2 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

2 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Cardiac output by thermodilution technique. Effect of injectate's volume and temperature on accuracy and reproducibility in the critically Ill patient

2 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.

2 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

2 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

2 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure

2 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Mechanisms of nitrate action and vascular tolerance

2 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Methionine restores the venodilative response to nitroglycerin after the development of tolerance

2 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Prevention of nitrate tolerance with angiotension converting enzyme inhibitors

2 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril

2 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure

2 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin

2 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure

2 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

2 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Interaction between hydralazine and nitrovasodilators in vascular smooth muscle

2 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.

2 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure

2 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure

2 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Dose requirements of hydralazine in patients with severe chronic congestive heart failure

2 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure

2 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects

2 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure

2 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure

2 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure

2 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.

2 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00368-1

2 June 2024

Identifiers

1 reference

27 December 2017

1 reference

27 December 2017